ARYx Therapeutics, Inc. Stock Other OTC
Equities
ARYX
US0433871094
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | 19.72 | Sales 2009 | - | Capitalization | 88.66M |
---|---|---|---|---|---|
Net income 2008 | -31M | Net income 2009 | -33M | EV / Sales 2008 | 4,019,605 x |
Net cash position 2008 | 29.9 | Net Debt 2009 | 2.37 | EV / Sales 2009 | - |
P/E ratio 2008 |
-1.76
x | P/E ratio 2009 |
-2.66
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
+9.15% | 106B | |
-1.08% | 104B | |
+7.05% | 23.25B | |
-11.55% | 22.5B | |
-7.15% | 18.7B | |
-37.08% | 17.95B | |
-9.91% | 16.99B | |
+7.55% | 14.26B | |
+40.04% | 12.76B |